Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Breast Liver Metastases – Incidence, Diagnosis And Outcome
A. L. Hoe, G. Royle, I. Taylor
Published 1991 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Breast liver metastases are uncommon and have not been well reported. We studied the clinical outcome of 47 patients who developed liver metastases out of 912 breast cancer patients treated between 1982 and 1987, an incidence of 5.2%. The median disease free interval prior to clinical liver metastases was 20.2 months (range 4–192 months). The most frequent clinical presentations were hepatomegaly (70%) and abdominal pain (34%). The diagnosis was confirmed on ultrasound scan in 72.7% patients. Thirty-one patients (70.5%) received specific treatment with both hormone and chemotherapy but only six showed any evidence of objective response, the majority of whom had metastases only in the liver. The median survival of treated patients was 4 months and absence of jaundice, response to treatment and liver metastases only were associated with significantly better survival. In conclusion breast liver metastases usually present as a manifestation of disseminated disease and have an appalling prognosis. When they occur as an initial site the prognosis is better but very few patients overall respond to conventional treatment.
This paper references
The pattern of metastases in human breast cancer: methodological aspects and influence of prognostic factors.
C. Kamby (1990)
Manifestations of metastatic tumors of the liver. A study of eighty-one patients subjected to needle biopsy.
L. Fenster (1961)
Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer
C. Kamby (1987)
Computed tomography, ultrasound, and scintigraphy of the liver in patients with colon or breast carcinoma: a prospective comparison.
P. Alderson (1983)
Secondary tumours of the liver
RA Willis (1973)
Incidence and methodological aspects of the occurrence of liver metastases in recurrent breast
T Nemato (1987)
Reporting results of cancer treatment
A. Miller (1981)
Significance of liver metastasis in women with disseminated breast cancer undergoing endocrine ablative surgery
T. Nemoto (1966)
Clinical course of breast cancer patients with liver metastases.
J. Zinser (1987)
Breast Cancer: Metastatic Patterns and Their Prognosis
O. Salazar (1988)
T. Walsh (1969)
A. Satterfield (1938)
Efficacy of peroperative liver function tests and ultrasound in detecting hepatic metastasis in carcinoma of the breast.
C. P. Clark (1988)
Tests for liver metastases in breast cancer: evaluation of liver scan and liver ultrasound.
L. De Rivas (1980)
Classification of patients with disseminated cancer of the breast
S. Cutler (1969)
Detection of liver metastases. A prospective study comparing liver enzymes, scintigraphy, ultrasonography and computed tomography
R. H. Schreve (1984)
Am Autopsy Study of Some Routes of Dissemination of Cancer of the Breast
E. Viadana (1973)
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.
R. Peto (1977)
undergoing endocrine ablative surgery
E Viadana (1966)
The topographic distribution of liver metastases. Its relation to surgical and isotope diagnosis
A Ozarda (1962)
Nonparametric Estimation from Incomplete Observations
E. L. Kaplan (1958)
A prospective study of hepatic imaging in the detection of metastatic disease.
T. Smith (1982)
Scintigraphic criteria for hepatic metastases from cancer of the colon and breast.
D. Drum (1976)
T. Warnes (1972)
Factors influencing survival in patients with untreated hepatic metastases.
B. Jaffe (1968)
UICC:TNM Classification of malignant tumours
P Hermanek (1987)
R. Willis (1951)
This paper is referenced by
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2011. September 10-14, 2011. Munich, Germany.
L. Tarantino (2011)
Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study
Hai-Yun Zhao (2018)
September 10-14 Munich, Germany CIRSE 2011
L. Tarantino (2011)
Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer
T. Vogl (2009)
Interstitial laser thermotherapy for liver tumours
M. Nikfarjam (2003)
Biopsy of liver metastasis for women with breast cancer: impact on survival.
E. Botteri (2012)
Contribuição da ultra-sonografia abdominal no seguimento de pacientes pós-tratamento do câncer mamário
A. C. Ferreira (2002)
Embolic Therapy for the Treatment of Liver Metastases 27
R. Winokur (2013)
Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review
S. Aoki (2020)
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women
G. Pentheroudakis (2005)
Serological Diagnosis of Liver Metastasis in Patients with Breast Cancer
R. Cao (2012)
ENZYMES AND ANTIOXIDANT AS BIOMARKERS IN BREAST CANCER
V. Pavithra (2014)
Experience with eribulin in patients with metastatic breast cancer and associated hepatic impairment: case studies.
Daniel Acosta-Eyzaguirre (2018)
Ablation of liver metastases: current status.
V. Flanders (2010)
A role for hepatic surgery in patients with liver metastatic breast cancer: review of literature.
N. Bacalbașa (2015)
Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.
M. F. Meloni (2009)
Surgical resection of a liver metastasis from breast cancer.
D. Selvakumar (2015)
Liver metastases from breast cancer: management of patients with significant liver dysfunction.
M. Mano (2005)
Breast cancer metastases in liver: laser-induced interstitial thermotherapy--local tumor control rate and survival data.
M. Mack (2004)
Benigne und maligne Tumoren der Mamma
D. Oertli (2006)
Hepatic Arterial Infusion Chemotherapy Is a Feasible Treatment Option for Breast Cancer with Liver-predominant Metastatic Disease
Jui-Hu Hsiao (2018)
Systematic review of early and long-term outcome of liver resection for metastatic breast cancer: Is there a survival benefit?
T. G. Yoo (2017)
A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome
J. Zhu (2009)
Prognostic significance of liver metastases as first site of generalisation in patients with breast cancer--a retrospective analysis.
M. Baur (2001)
Surgical management of breast cancer liver metastases.
Maria A. Cassera (2011)
BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase
S. Larsén (2014)
Improvement of survival and prospect of cure in patients with metastatic breast cancer
Y. Cheng (2011)
Resection of liver metastases in patients with breast cancer: survival and prognostic factors.
G. A. M. van Walsum (2012)
Prognostic Factors In Breast Cancer Patients With Hepatic Metastases: Impact Of Molecular Subtype And Local Hepatic Treatment
O. Ates (2016)
Open-configuration MR-guided microwave thermocoagulation therapy for metastatic liver tumors from breast cancer
H. Abe (2005)
Liver Metastasis: Update on Thermal and Nonthermal Ablative Therapies
D. López (2017)
Breast Cancer: Targets and Therapy Dovepress